Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with d-phenylalanine for colon specific drug delivery in inflammatory bowel disease" [Bioorg. Med. Chem. Lett. 17 (2007) 1897-1902] (DOI:10.1016/j.bmcl.2007.01.031);Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with d-phenylalanine for colon specific drug delivery in inflammatory bowel disease

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 7, 2007, Pages 1897-1902

  Dhaneshwar, Suneela S ^a   Gairola, Neha ^a   Kandpal, Mini ^a   Bhatt, Lokesh ^a   Vadnerkar, Gaurav ^a   Kadam, S S ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

5 Aminosalicylic acid; d Phenylalanine; Inflammatory bowel disease; Mutual azo prodrug

Indexed keywords

5 AMINOSALICYLIC ACID DEXTRO PHENYLALANINE CONJUGATE; AZO COMPOUND; DEXTRO PHENYLALANINE; MESALAZINE; PHOSPHATE; PRODRUG; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL TISSUE; ARTICLE; COLD STRESS; COLITIS; COLON; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG RELEASE; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENTERITIS; FECES ANALYSIS; FEMALE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; ULCEROGENESIS;

RATTUS;

EID: 33847681902     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.01.118     Document Type: Erratum

References (23)

1. Bonner G.F. South Med. J. 89 (1996) 556
2. Brzezinski A., Rankin G.B., Seidner D.L., and Lshner B.A. Clev. Clin. J. Med. 62 (1995) 317
3. Bonner G.B., and Ruderman W.B. Inflammopharmacology (1993), Kluwer Academic, Norwell-Mass 247-262
4. Chourasia M.K., and Jain S.K. J. Pharm. Sci. 6 (2003) 33
5. Sands B.E. Gastroenterology 118 (2000) S68
6. Sutherland L.R., Rothy D.E., and Beck P.L. Inflamm. Bowel. Dis. 3 (1997) 65
7. Mahmud N., Kamm M.A., and Dupas J.L. Gut 49 (2001) 552
8. Rao S.S.C., Read N.W., and Holdsworth C.D. Gut 28 (1987) 1474
9. Meyers B.E., Moonka D.K., and Davis R.H. Inflammation 3 (1979) 225
10. Rubinstein A., Nakar D., and Sintov A. Pharm. Res. 9 (1992) 276
11. Rainsford K.D. Proc. Br. Pharmacol. Soc. (1980) 226
12. Rainsford K.D. Agents Actions 5 (1975) 553
13. Morris G.P., Beck P.L., Herridge M.S., and Drew W.T. Gastroenterology 96 (1989) 795
14. Zingarelli B., Squadrito F., Graziani P., Camerini R., and Caputi A.P. Agents Actions 39 (1993) 150
15. Li T. World J. Gasteroenterol. 9 (2003) 1028
16. Indian Pharmacopoeia, 1996, Vol. II, Appendix 13, A144-145.
17. Nielsen N.M., and Bundgaard H. J. Pharm. Sci. 77 (1988) 285
18. Uekama K., Minami K., and Hirayama F. J. Med. Chem. 40 (1997) 2755
19. Dhaneshwar S., and Chaturvedi S.C. Indian Drugs 31 (1994) 374
20. Furniss B.S., Hannaford A.J., Smith P.W.G., and Tatchell A.R. Vogel's Textbook of Practical Organic Chemistry. 4th ed. (1978), The English Language Bookman, London 688-690
21. March J. Advanced Organic Chemistry-Reactions, Mechanisms and Structure. 3rd ed. (1986), Wiley Eastern Ltd 688-690
22. Yamada T., Marshall S., Specian R.D., and Grisham M.B. Gastroenterology 102 (1992) 1524
23. Hartmann G., Bidlingamaier C., Seigmund B., Albrich S., Schulze J., Tschoep K., Eigler A., Lehr H.A., and Endres S. J. Pharmacol. Exp. Ther. 292 (2000) 22